Felix Geissler
Geen lopende functies
Loopbaan van Felix Geissler
Eerdere bekende functies van Felix Geissler
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CURIS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-01-2022 | 01-01-2023 |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Felix Geissler
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| University of Innsbruck | Doctorate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Duitsland | 3 |
| Oostenrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 3 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
| Electronic Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Electronic Technology |
| Sanofi Corp. |
- Beurs
- Insiders
- Felix Geissler
- Ervaring
